ADA Report. Dulaglutide (Trulicity®) GLP-1 and CV outcomes in T2DM (REWIND): a double-blind, randomised placebo-controlled trial. 12% less MACE. The Lancet juni 10, 2019 5:54 f m Läs mer »
ADA Report. Insulin-Producing Beta Cells Are Not Irreversibly Lost in Early T2DM. DiREKT Trial juni 9, 2019 6:37 e m Läs mer »
ADA Report. CGM accuracy. Intermittent fasting. T2DM cut the pills in two. juni 9, 2019 3:53 e m Läs mer »
ADA Report. Very young T2DM high complication rate 20 yrs later. TODAY-2 juni 9, 2019 3:44 e m Läs mer »
ADA Report. T2DM can stay without insulin. Diabetes Remission Clinical Trial (DiRECT). juni 9, 2019 3:40 e m Läs mer »
ADA Report. What value should clinicians place on real-world evidence trial? juni 8, 2019 2:49 e m Läs mer »
